Desk› Healthcare› Shilpa Medicare Ltd
Shilpa Medicare Ltd
Filing rhythm · 60 trading days
27 filings · 11 material · busiest 2026-08-05
What it files
Filings
27 in the window
-
19 August 2026
GeneralDispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent /Depository Participants
Dispatch of letter to shareholders whose e-mail addresses are not registered with Company/ Registrar & Transfer Agent/ Depository Participants.
Company Update / General View filing →
-
18 August 2026
GeneralResponse On The News Item Captioned 'Shilpa Medicare Recalls Over 27K Vials Of Chemotherapy Drug In US' Published In The Online Edition Of The Economic Times On August 17, 2026 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Disclosure under Reg.30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Company Update / General View filing →
-
17 August 2026
-
14 August 2026
Newspaper PublicationNewspaper Publication
Newspaper Publication
Company Update / Newspaper Publication View filing →
-
13 August 2026
AGM / EGM39Th Annual General Meeting Notice
39th Annual General Meeting Notice
AGM/EGM / AGM View filing →
-
13 August 2026
Annual ReportReg. 34 (1) Annual Report.
Annual Report of Shilpa Medicare Limited for the FY 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
10 August 2026
Concall TranscriptEarnings Call Transcript
Q1FY27 earnings conference call transcript
Company Update / Earnings Call Transcript View filing →
-
5 August 2026
Board OutcomeBoard Meeting Outcome for Unaudited Financial Results For The Quarter Ended 30 June, 2026
Unaudited Financial Results for the Quarter ended 30 June 2026
Board Meeting / Outcome of Board Meeting View filing →
-
5 August 2026
ResultsUnaudited Standalone And Consolidated Financial Results For The Quarter Ended 30 June 2026
Unaudited standalone and consolidated Financial Results for the Quarter ended 30 June 2026
Result / Financial Results View filing →
-
5 August 2026
Record DateFinal Dividend For The FY 2025-26
The record date for determining the shareholders entitled for payment of final dividend for FY 2025-26, if declared at the 39th AGM is Friday, 4th September 2026.
Corp. Action / Record Date View filing →
-
5 August 2026
Investor PresentationInvestor Presentation
Investor Presentation for Q1FY27
Company Update / Investor Presentation View filing →
-
5 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Outcome
Audio link of the Investor Conference call for Q1 FY27
Company Update / Analyst / Investor Meet View filing →
-
3 August 2026
Change in ManagementChange in Management
Appointment of Dr. Uday N. Harle as Chief Executive Officer of Shilpa Biologicals Private Limited, a wholly owned subsidiary of Shilpa Medicare Limited w.e.f 03 August 2026. (Senior Managerial ....
Company Update / Change in Management View filing →
-
29 July 2026
Board MeetingBoard Meeting Intimation for Quarterly Financial Results
Shilpa Medicare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Unaudited financial results ....
Board Meeting / Board Meeting View filing →
-
29 July 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Investor conference call for Q1-FY27 is scheduled to be held on 05 August 2026
Company Update / Analyst / Investor Meet View filing →
-
16 July 2026
-
15 July 2026
Change in ManagementChange in Management
Resignation of Dr. Sridevi Khambhampaty, as Chief Executive Officer (CEO) of Shilpa Biologicals Private Limited, material subsidiary of Shilpa Medicare Limited.
Company Update / Change in Management View filing →
-
7 July 2026
Credit RatingCredit Rating
Intimation of Credit Rating
Company Update / Credit Rating View filing →
-
6 July 2026
Compliance CertificateCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of SEBI (DP) Regulation, 2018
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
30 June 2026
Press ReleasePress Release / Media Release
Shilpa Biologicals Pvt Ltd, a wholly owned subsidiary of Shilpa Medicare Limited enters into a Co-development and supply agreement with Orion Corporation, Finland
Company Update / Press Release / Media Release View filing →
-
26 June 2026
Newspaper PublicationNewspaper Publication
Newspaper Publication
Company Update / Newspaper Publication View filing →
-
25 June 2026
Trading WindowClosure of Trading Window
Intimation of Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 June 2026
Press ReleasePress Release / Media Release
Press Release on announcement of commissioning of a state-of-art Antibody-Drug Conjugate (ADC) GMP Manufacturing Facility by Shilpa Biologicals Private Limited, a material subsidiary of ....
Company Update / Press Release / Media Release View filing →
-
24 June 2026
Newspaper PublicationNewspaper Publication
Shilpa Medicare Limited has informed the exchange about the copy of news paper publication.
Company Update / Newspaper Publication View filing →
-
24 June 2026
GeneralM/S Shilpa Biologicals Pvt. Ltd, A Material Subsidiary Of Shilpa Medicare Limited And M/S Sartorius Stedim India Pvt. Ltd. Have Entered Into A Settlement Agreement
Shilpa Biologicals Pvt Ltd, a material subsidiary of Shilpa Medicare Ltd and M/s Sartorius Stedim India Pvt Ltd have entered into a settlement agreement
Company Update / General View filing →
-
23 June 2026
Postal BallotShareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizers Report along with Voting Results of Postal Ballot
AGM/EGM / Postal Ballot View filing →
-
3 June 2026
Press ReleasePress Release / Media Release
Shilpa Biocare Private Limited, a wholly owned Subsidiary of Shilpa Medicare Limited, intends to make a strategic equity partnership in Gate2Brain.
Company Update / Press Release / Media Release View filing →